Matthew Stanton Generation Bio Co. (GBIO) insider trading activity

Matthew Stanton is CHIEF SCIENTIFIC OFFICER of Generation Bio Co.. Currently has a direct ownership of 247,319 shares of GBIO, which is worth approximately $264,631. The most recent transaction as insider was on Oct 15, 2024, when has been sold 492 shares (Common Stock) at a price of $2.42 per share, resulting in proceeds of $1,190. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 247K

0.48% 3M change

5.45% 12M change

Total Value Held $264,631

Matthew Stanton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2024	SELL Payment of exercise price or tax liability	$1,190 $2.42 p/Share	492 Reduced 0.2%	247,319 Common Stock
Oct 15 2024	BUY Exercise of conversion of derivative security	-	1,674 Added 0.67%	247,811 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$1,441 $2.93 p/Share	492 Reduced 0.2%	246,137 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	-	1,674 Added 0.67%	246,629 Common Stock
Apr 15 2024	SELL Payment of exercise price or tax liability	$1,820 $3.7 p/Share	492 Reduced 0.2%	244,955 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	-	1,674 Added 0.68%	245,447 Common Stock
Jan 15 2024	SELL Payment of exercise price or tax liability	$9,353 $1.91 p/Share	4,897 Reduced 1.97%	243,773 Common Stock
Jan 15 2024	BUY Exercise of conversion of derivative security	-	14,131 Added 5.43%	246,093 Common Stock
Oct 15 2023	SELL Payment of exercise price or tax liability	$7,072 $3.24 p/Share	2,183 Reduced 0.92%	234,539 Common Stock
Oct 15 2023	BUY Exercise of conversion of derivative security	-	7,437 Added 3.05%	236,722 Common Stock
Jul 15 2023	SELL Payment of exercise price or tax liability	$11,089 $5.08 p/Share	2,183 Reduced 0.94%	229,285 Common Stock
Jul 15 2023	BUY Exercise of conversion of derivative security	-	7,437 Added 3.11%	231,468 Common Stock
Apr 15 2023	SELL Payment of exercise price or tax liability	$9,823 $4.5 p/Share	2,183 Reduced 0.97%	224,031 Common Stock
Apr 15 2023	BUY Exercise of conversion of derivative security	-	7,437 Added 3.18%	226,214 Common Stock
Jan 15 2023	SELL Payment of exercise price or tax liability	$13,147 $5.1 p/Share	2,578 Reduced 1.16%	218,777 Common Stock
Jan 15 2023	BUY Exercise of conversion of derivative security	-	7,438 Added 3.25%	221,355 Common Stock
Oct 15 2022	SELL Payment of exercise price or tax liability	$12,252 $5.61 p/Share	2,184 Reduced 1.01%	213,917 Common Stock
Oct 15 2022	BUY Exercise of conversion of derivative security	-	7,438 Added 3.33%	216,101 Common Stock
Jul 15 2022	SELL Payment of exercise price or tax liability	$31,355 $7.18 p/Share	4,367 Reduced 2.05%	208,663 Common Stock
Jul 15 2022	BUY Exercise of conversion of derivative security	-	14,876 Added 6.53%	213,030 Common Stock
Sep 14 2021	SELL Open market or private sale	$126,315 $28.07 p/Share	4,500 Reduced 2.22%	198,154 Common Stock
Sep 14 2021	BUY Exercise of conversion of derivative security	$20,655 $4.59 p/Share	4,500 Added 2.17%	202,654 Common Stock
Sep 10 2021	SELL Open market or private sale	$78,660 $26.22 p/Share	3,000 Reduced 1.49%	198,154 Common Stock
Sep 10 2021	BUY Exercise of conversion of derivative security	$13,770 $4.59 p/Share	3,000 Added 1.47%	201,154 Common Stock
Aug 23 2021	SELL Open market or private sale	$37,560 $25.04 p/Share	1,500 Reduced 0.75%	198,154 Common Stock

Matthew Stanton

CHIEF SCIENTIFIC OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Generation Bio Co. insider buys or sells GBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Generation Bio Co.

Track Activities on GBIO

Account